First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 7.52 USD 15.16% Market Closed
Updated: Jul 18, 2024
Have any thoughts about
Burning Rock Biotech Ltd?
Write Note

Wall Street
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

Wall Street analysts forecast BNR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNR is 4.03 USD .

Lowest
Price Target
Not Available
Average
Price Target
4.03 USD
46% Downside
Highest
Price Target
Not Available
Burning Rock Biotech Ltd Competitors:
Price Targets
BCRX
BioCryst Pharmaceuticals Inc
99% Upside
GNFT
Genfit SA
119% Upside
PYXS
Pyxis Oncology Inc
173% Upside
358570
GI Innovation Inc
94% Upside
HOWL
Werewolf Therapeutics Inc
335% Upside
4599
StemRIM Inc
52% Upside
BAVA
Bavarian Nordic A/S
45% Upside
MREO
Mereo Biopharma Group PLC
90% Upside

Revenue
Forecast

Revenue Estimate
Burning Rock Biotech Ltd

For the last 5 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 21%. The projected CAGR for the next 3 years is 29%.

21%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
47%
Average Beat

Net Income
Forecast

Net Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
48%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNR's stock price target?
Price Target
4.03 USD

According to Wall Street analysts, the average 1-year price target for BNR is 4.03 USD .

What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
29%

For the last 5 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 21%. The projected CAGR for the next 3 years is 29%.